Home 2023

HIV drug discovery

Dormant HIV May Actively Impact Immune Response
Infectious Diseases

Dormant HIV May Actively Impact Immune Response

Christina Jackson -
0
AGT Spins Out Addimmune, Focusing on Functional HIV Cure
Drug Discovery

AGT Spins Out Addimmune, Focusing on Functional HIV Cure

Alex Philippidis -
0
Latent HIV Reservoir in CSF May Pose Treatment Challenges
Infectious Diseases

Latent HIV Reservoir in CSF May Pose Treatment Challenges

Julianna LeMieux, PhD -
0
HIV Drug Candidate Opens “Shock and Kill” Possibilities
Drug Discovery

HIV Drug Candidate Opens “Shock and Kill” Possibilities

Kevin Mayer -
0
Low Patient Enrollment Threatens Cancer Trials
Insights

Low Patient Enrollment Threatens Cancer Trials

Alex Philippidis -
0
FDA Approves Viiv Healthcare’s HIV-1 Treatment Tivicay
Infectious Diseases

FDA Approves Viiv Healthcare’s HIV-1 Treatment Tivicay

GEN Staff Writer -
0
HIV Drug Consortium Wins Over $5M in EU Funding
Industry News

HIV Drug Consortium Wins Over $5M in EU Funding

GEN Staff Writer -
0
FDA Okays BI’s Once-Daily Extended-Release Viramune Tablet for HIV-1 Therapy
Infectious Diseases

FDA Okays BI’s Once-Daily Extended-Release Viramune Tablet for HIV-1 Therapy

GEN Staff Writer -
0
Tobira Scores $31M to Conduct Mid-Stage Trial with HIV Drug
Industry News

Tobira Scores $31M to Conduct Mid-Stage Trial with HIV Drug

GEN Staff Writer -
0
Could Stapling Revive Peptide Therapeutics?
Insights

Could Stapling Revive Peptide Therapeutics?

Patricia F. Fitzpatrick Dimond -
0
123Page 1 of 3
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.